ESR1 and cancer: Assessment of cancer estrogen receptor-alpha expression in breast carcinomas is essential in their management, as breast cancer estrogen receptor (ER) expression is a strong predictive factor for response to hormonal therapies, such as tamoxifen, and also has prognostic value [5–7].